GB0611241D0 - The treatment of increased sebum production - Google Patents

The treatment of increased sebum production

Info

Publication number
GB0611241D0
GB0611241D0 GBGB0611241.1A GB0611241A GB0611241D0 GB 0611241 D0 GB0611241 D0 GB 0611241D0 GB 0611241 A GB0611241 A GB 0611241A GB 0611241 D0 GB0611241 D0 GB 0611241D0
Authority
GB
United Kingdom
Prior art keywords
treatment
sebum production
increased sebum
increased
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0611241.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daniolabs Ltd
Original Assignee
Daniolabs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daniolabs Ltd filed Critical Daniolabs Ltd
Priority to GBGB0611241.1A priority Critical patent/GB0611241D0/en
Publication of GB0611241D0 publication Critical patent/GB0611241D0/en
Priority to PCT/GB2007/002101 priority patent/WO2008059190A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0611241.1A 2006-06-07 2006-06-07 The treatment of increased sebum production Ceased GB0611241D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0611241.1A GB0611241D0 (en) 2006-06-07 2006-06-07 The treatment of increased sebum production
PCT/GB2007/002101 WO2008059190A1 (en) 2006-06-07 2007-06-07 Treatment of excess sebum production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0611241.1A GB0611241D0 (en) 2006-06-07 2006-06-07 The treatment of increased sebum production

Publications (1)

Publication Number Publication Date
GB0611241D0 true GB0611241D0 (en) 2006-07-19

Family

ID=36745424

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0611241.1A Ceased GB0611241D0 (en) 2006-06-07 2006-06-07 The treatment of increased sebum production

Country Status (2)

Country Link
GB (1) GB0611241D0 (en)
WO (1) WO2008059190A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ570492A (en) 2006-02-13 2011-08-26 Orient Pharma Samoa Co Ltd Combination of alpha-2 receptor agonist (clonidin) and an anti-muscarinic agent (oxybutynin) for the treatment of excess salivation or drooling
CA2786598A1 (en) * 2010-01-08 2011-07-14 Recro Pharma, Inc. Topical transdermal dexmedetomidine compositions and methods of use thereof
BR112013012112A2 (en) * 2010-11-16 2016-09-27 Allergan Inc pharmaceutical compositions comprising (3- (1-h-imidazol-4-yl) ethyl) -2-methylphenyl) methanol
AU2012340806B2 (en) 2011-11-21 2017-10-19 Allergan, Inc. Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
WO2013090278A2 (en) 2011-12-11 2013-06-20 Recro Pharma, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
KR101827980B1 (en) 2013-10-07 2018-02-13 테이코쿠 팔마 유에스에이, 인코포레이티드 Dexmedetomidine transdermal delivery devices and methods for using the same
KR101831290B1 (en) 2013-10-07 2018-02-22 테이코쿠 팔마 유에스에이, 인코포레이티드 Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
ES2847936T3 (en) 2013-10-07 2021-08-04 Teikoku Pharma Usa Inc Methods and compositions for the transdermal delivery of a non-sedating amount of dexmedetomidine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050020600A1 (en) * 2003-07-23 2005-01-27 Scherer Warren J. Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists
EP2481412B1 (en) * 2004-05-25 2017-09-27 Galderma Pharma S.A. Compounds, formulations, and methods for treating or preventing inflammatory skin disorders

Also Published As

Publication number Publication date
WO2008059190A1 (en) 2008-05-22

Similar Documents

Publication Publication Date Title
GB0610867D0 (en) Treatment of pain
EP1982660A4 (en) Treatment endoscope
EP2068864A4 (en) Therapeutic uses of urolithins
EP2059498A4 (en) Treatment of cancer
IL193748A0 (en) Treatment of pain
IL195906A0 (en) Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
EP2049139A4 (en) Treatment of ras-expressing tumors
EP1968591A4 (en) Treatment of synucleinopathies
GB0611240D0 (en) The treatment of increased sebum production
IL205137A0 (en) 5-cyanothienopyridines for the treatment of tumours
GB0611241D0 (en) The treatment of increased sebum production
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
GB0610868D0 (en) Treatment of pain
GB0607952D0 (en) Novel treatment
GB0723100D0 (en) Treatment of HFnEF
EP2164494A4 (en) Methods of treatment
IL194798A0 (en) Treatment of melanoma
GB0623740D0 (en) Treatment of disease
GB0616450D0 (en) Treatment of pain
GB0622136D0 (en) Treatment of gastrointestinal diseases
GB0602857D0 (en) The treatment of sialorrhoea
GB0814043D0 (en) The treatment of skin disorders
HK1145282A1 (en) Treatment of sleep disorders
GB0622137D0 (en) Treatment of gastrointestinal diseases
GB0602855D0 (en) The Treatment Of Sialorrhoea

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)